Evogene Ltd. (TLV:EVGN)

Evogene Revenue

Evogene had revenue of $312.00K USD in the quarter ending September 30, 2025, a decrease of -82.63%. This brings the company's revenue in the last twelve months to $5.25M, down -26.75% year-over-year. In the year 2024, Evogene had annual revenue of $8.51M with 50.90% growth.

• Revenue (ttm): $5.25M
• Revenue Growth: -26.75%
• P/S Ratio: 0.90
• Revenue / Employee: $44.88K
• Employees: 117
• Market Cap: 23.91M ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.51M	2.87M	50.90%
Dec 31, 2023	5.64M	3.97M	236.72%
Dec 31, 2022	1.68M	745.00K	80.11%
Dec 31, 2021	930.00K	-110.00K	-10.58%
Dec 31, 2020	1.04M	287.00K	38.11%
Dec 31, 2019	753.00K	-994.00K	-56.90%
Dec 31, 2018	1.75M	-1.63M	-48.33%
Dec 31, 2017	3.38M	-3.16M	-48.30%
Dec 31, 2016	6.54M	-4.59M	-41.23%
Dec 31, 2015	11.13M	-3.38M	-23.31%
Dec 31, 2014	14.51M	-3.07M	-17.46%
Dec 31, 2013	17.58M	509.00K	2.98%
Dec 31, 2012	17.07M	2.17M	14.57%
Dec 31, 2011	14.90M	2.34M	18.61%
Dec 31, 2010	12.56M	-	-